4-fluoro-N-((R)-2,2,2-trifluoro-1-(4-((1S,2S)-2-(pyridin-3-yl)cyclopropane-1-carboxamido)phenyl)ethyl)benzamide

ID: ALA4203945

PubChem CID: 145977793

Max Phase: Preclinical

Molecular Formula: C24H19F4N3O2

Molecular Weight: 457.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N[C@H](c1ccc(NC(=O)[C@H]2C[C@@H]2c2cccnc2)cc1)C(F)(F)F)c1ccc(F)cc1

Standard InChI:  InChI=1S/C24H19F4N3O2/c25-17-7-3-15(4-8-17)22(32)31-21(24(26,27)28)14-5-9-18(10-6-14)30-23(33)20-12-19(20)16-2-1-11-29-13-16/h1-11,13,19-21H,12H2,(H,30,33)(H,31,32)/t19-,20+,21-/m1/s1

Standard InChI Key:  OYFJUOHKLAJUET-QHAWAJNXSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   35.9839  -28.7048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9827  -29.5285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6949  -29.9375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.4087  -29.5280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4059  -28.7012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6931  -28.2918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5398  -28.2805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2532  -28.6906    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.5368  -27.4592    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.9635  -28.2752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6687  -28.6870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.3785  -28.2723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.3759  -27.4501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6576  -27.0443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9548  -27.4573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.0857  -27.0379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7996  -27.4429    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.1152  -28.2873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8295  -28.6959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8262  -27.8730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8248  -29.5097    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   38.1108  -27.4667    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   44.5041  -27.0289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2149  -27.4321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4979  -26.2118    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.0815  -26.2207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2172  -28.2478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.9272  -28.6510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.6327  -28.2370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.6239  -27.4156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.9134  -27.0161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7871  -25.8085    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   42.3717  -25.8157    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   43.0759  -25.4031    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   47.3441  -28.6392    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5 18  1  0
 19  7  1  0
  7  8  1  0
  7  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 13 16  1  0
 16 17  1  0
 19 18  1  0
 19 20  1  0
 18 20  1  0
 19 21  1  1
 18 22  1  6
 17 23  1  0
 23 24  1  0
 23 25  2  0
 16 26  1  6
 24 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 24  1  0
 26 32  1  0
 26 33  1  0
 26 34  1  0
 29 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4203945

    ---

Associated Targets(Human)

A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
COR-L23 (253 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 457.43Molecular Weight (Monoisotopic): 457.1413AlogP: 5.00#Rotatable Bonds: 6
Polar Surface Area: 71.09Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.85CX Basic pKa: 4.90CX LogP: 4.15CX LogD: 4.15
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.51Np Likeness Score: -1.43

References

1. Palacios DS, Meredith E, Kawanami T, Adams C, Chen X, Darsigny V, Geno E, Palermo M, Baird D, Boynton G, Busby SA, George EL, Guy C, Hewett J, Tierney L, Thigale S, Weihofen W, Wang L, White N, Yin M, Argikar UA..  (2018)  Structure based design of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors from a phenotypic screen.,  28  (3): [PMID:29275937] [10.1016/j.bmcl.2017.12.037]

Source